Biotechnology News and Research

RSS

Environmental and biomedical applications of enzyme inhibitors

Enzyme inhibitors play a pivotal role in pharmaceutical and nutraceutical industries. The primary understanding of the action of inhibitors helps pharmacologists during the design process for developing new therapeutic drugs.

8 Sep 2020

First 'plug and play' brain prosthesis demonstrated in a person with paralysis

In a significant advance, UC San Francisco Weill Institute for Neurosciences researchers working towards a brain-controlled prosthetic limb have shown that machine learning techniques helped an individual with paralysis learn to control a computer cursor using their brain activity without requiring extensive daily retraining, which has been a requirement of all past brain-computer interface efforts.

7 Sep 2020

Early-phase Russian trials reveal safety and immunogenicity of two formulations of a two-part vaccine

Results from two early-phase Russian non-randomised vaccine trials (Sputnik V) in a total of 76 people are published today in The Lancet, finding that two formulations of a two-part vaccine have a good safety profile with no serious adverse events detected over 42 days, and induce antibody responses in all participants within 21 days.

5 Sep 2020

AXT add LabTIE International’s innovative life science solutions to their product range

AXT has further consolidated its position as a diversified supplier of life science products with the addition of LabTIE International’s innovative range of laboratory products and consumables.

From AXT Pty Ltd 4 Sep 2020

Researchers to create integrated global platform for longevity biotechnology, aging research

Deep Longevity, Inc (DLI), a leader in artificial intelligence for aging and longevity research announced that it had entered into the agreement to be acquired by Regent Pacific to create the integrated global platform for longevity biotechnology and aging research.

4 Sep 2020

New wearable solution allows patients to receive treatment without leaving home

The rapid increase of life-threatening antibiotic-resistant infections has resulted in challenging wound complications with limited choices of effective treatments. About 6 million people in the United States are affected by chronic wounds.

3 Sep 2020

AAV gene therapy often leads to dorsal root ganglion pathology, show studies

A meta-analysis of non-human primate (NHP) studies showed that adeno-associated virus (AAV) gene therapy often caused dorsal root ganglion (DRG) pathology.

3 Sep 2020

Major UK study launched to assess the impact of COVID-19 on cancer patients

A new UK study has been launched to assess the impact of covid-19 on people with cancer.

2 Sep 2020

Study offers a possible explanation for prevalence of autism spectrum disorder

Recent estimates indicate a prevalence of autism spectrum disorder (ASD) in the United States of 1 in 59 children with a well-established 4:1 male predominance.

2 Sep 2020

Innovative technique tracks human milk nutrients in infant gut microbiome

A new study in mice helps explain why gut microbiomes of breastfed infants can differ greatly from those of formula-fed infants.

1 Sep 2020

New EU research project seeks to kickstart the development of "Organoid Cell Atlas"

HCA|Organoid is a new EU research project that combines single-cell profiling and organoid technology to validate organoids as faithful models of human biology.

31 Aug 2020

New microgel drug delivery method could improve effectiveness of pancreatic islet transplants

Pancreatic islet transplants, which revive insulin production to treat type 1 diabetes, only last an average of three years.

31 Aug 2020

Study may help explain the symptoms and organs involved with SARS-CoV-2 infection

A study of a gateway receptor for SARS-CoV-2 led by Walter Lukiw, PhD, Professor of Neuroscience, Neurology and Ophthalmology at LSU Health New Orleans' Neuroscience Center of Excellence and School of Medicine, may help explain the wide variety of symptoms and organs involved with SARS-CoV-2 infection and COVID-19.

28 Aug 2020

Inhibiting STING activation could be new therapeutic strategy to treat ALS and FTD

Alberto Yáñez Boyer, Ramón y Cajal researcher at BIOTECMED (Interdisciplinary Research Structure in Biotechnology and Biomedicine) and the Department of Microbiology and Ecology at the University of Valencia (UV), participates in a study on the C9orf72 gene and its mutations in the immune system.

28 Aug 2020

Axol Bioscience appoints Liam Taylor as Chief Executive Officer

Axol Bioscience today announced the appointment of Liam Taylor as CEO. Liam will focus on maximizing its iPSC technologies, products, and services.

From Axol Bioscience Ltd 27 Aug 2020

Thermo Scientific Smart-Vue Pro Remote Monitoring Solution supports optimal sample safety and integrity

Biotechnology, pharmaceutical, clinical and academic laboratories can now benefit from a next-generation remote monitoring solution designed to enable superior levels of sample protection, workflow efficiencies, asset/cost optimization and regulatory compliance.

From Thermo Fisher Scientific Inc. 27 Aug 2020

Heat Biologics SARS-CoV-2 vaccine generates potent T cell response in pre-clinical trial

The COVID-19 pandemic is still creating economic and health-related impact over the world. A new study published on the preprint server bioRxiv in August 2020 shows that a gp96-Ig-secreting vaccine candidate based on the expression of full-length spike protein generates a potent T cell response.

26 Aug 2020

New aging biomarkers to be presented at 7th annual ARDD conference

Deep Longevity, a global science-driven longevity and performance management company utilizing the latest advances in artificial intelligence and aging research will present new research and tools for tracking human biological aging at the 7th annual Aging Research and Drug Discovery (ARDD) conference.

25 Aug 2020

New strategies automate the assessment of stored red blood cell quality

Each year, nearly 120 million units of donated blood flow from donor veins into storage bags at collection centres around the world. The fluid is packed, processed and reserved for later use. But once outside the body, stored red blood cells (RBCs) undergo continuous deterioration. By day 42 in most countries, the products are no longer usable.